Kolon Life Science Statistics

Total Valuation

KOSDAQ:102940 has a market cap or net worth of KRW 437.30 billion. The enterprise value is 561.68 billion.

Market Cap	437.30B
Enterprise Value	561.68B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:102940 has 12.42 million shares outstanding. The number of shares has increased by 6.82% in one year.

Current Share Class	12.42M
Shares Outstanding	12.42M
Shares Change (YoY)	+6.82%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	18.06%
Owned by Institutions (%)	0.24%
Float	6.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.61
PB Ratio	1.45
P/TBV Ratio	1.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.20
EV / Sales	3.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.81

Financial Position

The company has a current ratio of 0.50, with a Debt / Equity ratio of 0.44.

Current Ratio	0.50
Quick Ratio	0.22
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-6.06
Interest Coverage	-2.41

Financial Efficiency

Return on equity (ROE) is -33.86% and return on invested capital (ROIC) is -3.23%.

Return on Equity (ROE)	-33.86%
Return on Assets (ROA)	-2.43%
Return on Invested Capital (ROIC)	-3.23%
Return on Capital Employed (ROCE)	-4.58%
Revenue Per Employee	393.57M
Profits Per Employee	-183.24M
Employee Count	426
Asset Turnover	0.35
Inventory Turnover	2.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +70.46% in the last 52 weeks. The beta is -0.23, so KOSDAQ:102940's price volatility has been lower than the market average.

Beta (5Y)	-0.23
52-Week Price Change	+70.46%
50-Day Moving Average	28,307.00
200-Day Moving Average	24,408.70
Relative Strength Index (RSI)	67.15
Average Volume (20 Days)	100,799

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:102940 had revenue of KRW 167.66 billion and -78.06 billion in losses. Loss per share was -6,510.60.

Revenue	167.66B
Gross Profit	19.80B
Operating Income	-18.53B
Pretax Income	-78.06B
Net Income	-78.06B
EBITDA	-9.46B
EBIT	-18.53B
Loss Per Share	-6,510.60

Full Income Statement

Balance Sheet

The company has 7.41 billion in cash and 131.79 billion in debt, giving a net cash position of -124.37 billion or -10,011.36 per share.

Cash & Cash Equivalents	7.41B
Total Debt	131.79B
Net Cash	-124.37B
Net Cash Per Share	-10,011.36
Equity (Book Value)	301.40B
Book Value Per Share	24,260.75
Working Capital	-98.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -751.49 million and capital expenditures -21.01 billion, giving a free cash flow of -21.76 billion.

Operating Cash Flow	-751.49M
Capital Expenditures	-21.01B
Free Cash Flow	-21.76B
FCF Per Share	-1,751.43

Full Cash Flow Statement

Margins

Gross margin is 11.81%, with operating and profit margins of -11.05% and -46.56%.

Gross Margin	11.81%
Operating Margin	-11.05%
Pretax Margin	-46.56%
Profit Margin	-46.56%
EBITDA Margin	-5.64%
EBIT Margin	-11.05%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:102940 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.82%
Shareholder Yield	n/a
Earnings Yield	-17.85%
FCF Yield	-4.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 27, 2017
Split Type	Forward
Split Ratio	1.5

Scores

KOSDAQ:102940 has an Altman Z-Score of 0.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.02
Piotroski F-Score	3